Apellis Pharmaceuticals shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Apellis Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Apellis Pharmaceuticals held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Apellis Pharmaceuticals by Rhumbline Advisers
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $3.6M | 126k | 28.84 |
2024-06-30 | $4.7M | 124k | 38.36 |
2024-03-31 | $7.1M | 121k | 58.78 |
2023-12-31 | $8.0M | 134k | 59.86 |
2023-09-30 | $5.0M | 132k | 38.04 |
2023-06-30 | $12M | 133k | 91.10 |
2023-03-31 | $8.6M | 131k | 65.96 |
2022-12-31 | $6.8M | 131k | 51.71 |
2022-09-30 | $8.4M | 123k | 68.30 |
2022-06-30 | $5.0M | 110k | 45.22 |
2022-03-31 | $4.0M | 78k | 50.81 |
2021-12-31 | $3.5M | 74k | 47.28 |
2021-09-30 | $2.3M | 69k | 32.96 |
2021-06-30 | $4.2M | 67k | 63.20 |
2021-03-31 | $2.8M | 65k | 42.91 |
2020-12-31 | $4.3M | 75k | 57.20 |
2020-09-30 | $2.2M | 74k | 30.18 |
2020-06-30 | $3.0M | 90k | 32.66 |
2020-03-31 | $2.1M | 77k | 26.78 |
2019-12-31 | $2.0M | 65k | 30.62 |
2019-09-30 | $1.5M | 62k | 24.09 |
2019-06-30 | $1.6M | 62k | 25.33 |
2019-03-31 | $905k | 46k | 19.50 |
2018-12-31 | $620k | 47k | 13.18 |
2018-09-30 | $566k | 32k | 17.79 |
2018-06-30 | $747k | 34k | 22.00 |
2018-03-31 | $206k | 9.3k | 22.13 |